Lv1
30 积分 2022-02-05 加入
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD
4天前
已完结
Association of metabolic dysfunction-associated steatotic liver disease onset age with risk of incident type 2 diabetes
5天前
已关闭
Metabolic Dysfunction–Associated Steatotic Liver Disease
8天前
已完结
Cardiovascular or mortality risk of controlled hypertension and importance of physical activity
1个月前
已完结
Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults
1个月前
已完结
Comprehensive assessment of the causal effects and metabolite mediators of glucose-lowering drug targets on cardio-renal-liver-metabolic health
1个月前
已完结
Global burden of metabolic diseases, 1990–2021
1个月前
已完结
Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021
3个月前
已完结
Mortality and Cumulative Cardiovascular Risk Factor Control in Patients with Type 2 Diabetes: A Nationwide Population-Based Cohort Study
6个月前
已完结
Association between longitudinal weight change and clinical outcome in individuals with MASLD
7个月前
已完结
皖公网安备34019202002308
